Diretriz da USPSTF | Use de aspirina na prevenção de doença cardiovascular.

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement – JAMA

Entrevista com o autor: USPSTF Recommendation: Aspirin Use for Cardiovascular Disease – JAMA

Estudo modelo: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force – JAMA

Relatório de evidência: Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Página do paciente: Use of Aspirin to Prevent Cardiovascular Disease – JAMA

Editoriais:

Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force

Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma – JAMA Internal Medicine

Aspirin for Primary Prevention—Time to Rethink Our Approach – JAMA Network Open

USPSTF Report on Aspirin for Primary Prevention – JAMA Cardiology

Comentários:

USPSTF Report on Aspirin for Primary Prevention – American College of Cardiology

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention – TCTMD

Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says – STAT

U.S. Task Force Rejects Daily Aspirin for Heart Health in People Over 60 – HealthDay